Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-15 5:04 pm Purchase |
2025-03-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BlackRock Portfolio Management LLC | 4,479,086 7.700% |
4,479,086 (New Position) |
Filing History |
| 2025-02-07 1:40 pm Sale |
2025-01-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BLACKROCK INC BLK |
4,699,280 8.100% |
-4,404,924 (-48.38%) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BLACKROCK INC BLK |
9,104,204 15.600% |
757,837 (+9.08%) |
Filing History |
| 2024-02-13 5:16 pm Sale |
2023-12-29 | 13G | Vanda Pharmaceuticals Inc. VNDA |
The Vanguard Group | 3,456,087 6.010% |
-536,079 (-13.43%) |
Filing History |
| 2024-02-13 10:53 am Purchase |
2023-12-29 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Renaissance Technologies LLC | 3,681,125 6.400% |
791,700 (+27.40%) |
Filing History |
| 2024-02-09 09:59 am Sale |
2024-02-14 | 13G | Vanda Pharmaceuticals Inc. VNDA |
DIMENSIONAL FUND ADVISORS INC | 1,967,985 3.400% |
-885,847 (-31.04%) |
Filing History |
| 2024-01-23 11:52 am Purchase |
2023-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BLACKROCK INC BLK |
8,346,367 14.500% |
1,587,250 (+23.48%) |
Filing History |
| 2024-01-22 11:26 am Sale |
2023-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
1,228,096 2.130% |
-2,499,702 (-67.06%) |
Filing History |
| 2023-10-06 2:34 pm Sale |
2023-09-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BLACKROCK INC BLK |
6,759,117 11.800% |
-3,567,497 (-34.55%) |
Filing History |
| 2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Palo Alto Investors LP | 1,087,064 1.420% |
-1,747,180 (-61.65%) |
Filing History |
| 2023-02-14 1:34 pm Sale |
2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Macquarie Group Limited | 1,323,547 2.340% |
-1,589,924 (-54.57%) |
Filing History |
| 2023-02-13 11:33 am Sale |
2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Renaissance Technologies LLC | 2,889,425 5.090% |
-322,789 (-10.05%) |
Filing History |
| 2023-02-10 2:42 pm Purchase |
2023-02-14 | 13G | Vanda Pharmaceuticals Inc. VNDA |
DIMENSIONAL FUND ADVISORS INC | 2,853,832 5.000% |
2,853,832 (New Position) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA |
The Vanguard Group | 3,992,166 7.050% |
115,482 (+2.98%) |
Filing History |
| 2023-02-07 2:24 pm Purchase |
2022-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
3,727,798 6.590% |
400,365 (+12.03%) |
Filing History |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
BLACKROCK INC BLK |
10,326,614 18.200% |
501,239 (+5.10%) |
Filing History |
| 2022-02-14 9:56 pm Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Armistice Capital, LLC | 0 0.000% |
-5,399,277 (Position Closed) |
Filing History |
| 2022-02-14 5:08 pm Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Palo Alto Investors LP | 2,834,244 5.090% |
-1,396,304 (-33.01%) |
Filing History |
| 2022-02-14 11:15 am Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
Macquarie Group Limited | 2,913,471 5.230% |
-278,563 (-8.73%) |
Filing History |
| 2022-02-11 9:12 pm Purchase |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
STATE STREET CORP STT |
3,327,433 5.970% |
123,529 (+3.86%) |
Filing History |